Pure Global
NCT06381115

App-Based Optimization of Long-Term CPAP Adherence and Quality of Life

An App-Based, Precision Medicine Approach to Optimize Long-Term CPAP Adherence and Quality of Life
Mayo Clinic·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Obstructive Sleep Apnea
Drug/Device/Intervention
SleepWell24 Application
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Mayo Clinic
Location
Scottsdale,Rochester, United States of America
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Nov 01, 2024
Enrollment
40 participants
Primary outcome

CPAP Adoption,Change in Quality of Life

Summary

The purpose of this study is to optimize the time of CPAP usage to at least 6 hours a night
 for 6 nights per week for people who have OSA with the help of a smartphone application
 called SmartWell24. This application aims to target CPAP adherence.

ICD-10 classifications
Sleep apnoeaSleep disordersSleep disorder, unspecifiedPrimary sleep apnoea of newbornNonorganic sleep disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06381115
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06381115 through Pure Global AI's free database. This phase not specified trial is sponsored by Mayo Clinic and is currently Not yet recruiting. The study focuses on Obstructive Sleep Apnea. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.